There is substantial evidence that HLA-G can contribute to tumor immune evasion: HLA-G expression on tumor cells or secretion by bystander cells was found in various cancers and in some of these was associated with poor outcome [22–25]. This evidence concerns the gene HLA-G and neoplasm.